Anders Bjartell
71 – 80 of 361
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
(
- Contribution to journal › Article
-
Mark
A European Registry Evaluating Symptomatic Effectiveness of Pharmacologically Treated Patients with Lower Urinary Tract Symptoms due to Benign Prostatic Enlargement : Lessons Learned
(
- Contribution to journal › Article
-
Mark
Identification of a serum biomarker signature associated with metastatic prostate cancer
(
- Contribution to journal › Article
-
Mark
Contemporary use of phytotherapy in patients with lower urinary tract symptoms due to benign prostatic hyperplasia : results from the EVOLUTION European registry
(
- Contribution to journal › Article
-
Mark
Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial
(
- Contribution to journal › Article
-
Mark
IMAGINE—IMpact Assessment of Guidelines Implementation and Education : The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance
(
- Contribution to journal › Article
-
Mark
An Artificial Intelligence-based Support Tool for Automation and Standardisation of Gleason Grading in Prostate Biopsies
(
- Contribution to journal › Article
-
Mark
Bringing onco‐innovation to Europe’s healthcare systems : The potential of biomarker testing, real world evidence, tumour agnostic therapies to empower personalised medicine
(
- Contribution to journal › Article
-
Mark
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19) : a structured summary of a study protocol for a randomised controlled trial
(
- Contribution to journal › Letter